Immunization Integration Program

IIP Testing and Recognition Initiative

The Centers for Disease Control and Prevention (CDC), American Immunization Registry Association (AIRA), Drummond Group and HIMSS have come together to develop the IIP Testing and Recognition initiative which gives EHR developers the opportunity to adopt, demonstrate and raise awareness of their software product’s inclusion of high-priority immunization capabilities. This was developed through a consensus process involving experts and leaders representing IIS, EHRs and other health IT, HIEs, clinicians, public health and other critical partners. Undergoing IIP Testing and Recognition is offered at no-cost to health IT market suppliers and testing is powered by the National Institute of Standards and Technology (NIST) in collaboration with Drummond Group as the authorized testing body.

The IIP Testing and Recognition initiative has been approved by the Office of the National Coordinator for Health Information Technology (ONC) as an alternative testing method for (f)(1) Transmission to immunization registries certification criteria within the ONC Health IT Certification Program. ONC acts as a strategic advisor to IIP testing.

Pipeline Approach

A pipeline approach has been developed to identify opportunities for strategic application of the IIP Collaborative’s recommended solutions to testing within the Testing and Recognition initiative. Updates to the Test Plan are made regularly and include efforts resulting from work by the IIP Collaborative.

As the IIP evolves, additional testing capabilities may be added, with the goal to continue to improve immunization interoperability and information sharing with IIS. New testing capabilities will be introduced as discovery and eventually become a part of the trial or required set of testing capabilities.

Product Testing Eligibility

Criteria have been developed to define appropriate candidates for IIP testing including:

• Vendor product must be an electronic health record (EHR), as defined by HIMSS as: “an electronic record of health-related information on an individual that conforms to nationally recognized interoperability standards and that can be created, managed, and consulted by authorized clinicians and staff across more than one health care organization”
• Health IT market suppliers must clearly declare the product and version/release to be tested and recognized and provide the anticipated deployment schedule
• Health IT market suppliers must clearly declare if other products are being used to meet any of the capabilities tested through the process
• Health IT market suppliers must be willing to participate in evaluation activities and re-testing as appropriate
• A product does not need to be fully implemented in a production environment, but priority will be given to products and versions currently implemented in clinical locations providing immunizations

Join Our Leaders

Join other industry leaders and become an IIP recognized vendor!